September 03, 2009
The Perclose ProGlide 6 Fr. Suture-Mediated Closure System delivers a secure, reliable vessel closure to provide…
September 03, 2009
September 3, 2009 – Percutaneous cardiac valve maker Evalve Inc. announced treatment this week of the first group of…
September 03, 2009
September 3, 2009 – Important new findings in patients with angina participating in the BEAUTIFUL study show that there…
September 03, 2009
September 3, 2009 – ZOLL Medical Corp. received approval from the FDA to market and sell a new model of the LifeVest…
September 03, 2009
The HI-TORQUE Versacore .035 Guide Wire is a peripheral guide wire is designed for routine diagnostic and device…
September 03, 2009
September 3, 2009 – On Tuesday, Aug. 11, an 82-year old New Orleans resident with severe aortic stenosis successfully…
September 03, 2009
The FoxCross PTA Catheter is a next-generation .035 balloon dilatation catheter is used to open peripheral arteries…
September 03, 2009
September 3, 2009 – Abbott said last week it received approval from Health Canada for the XIENCE V Everolimus-Eluting…
September 03, 2009
September 2, 2009 – Edwards Lifesciences Corp. said this week it completed enrollment in its 1,040-patient randomized…
September 03, 2009
September 3, 2009 – Boston Scientific Corp. said Tuesday long-term data from the Prevention of Sudden Cardiac Death II…
September 03, 2009
September 3, 2009 – The OASIS study group presented initial results of the CURRENT-OASIS 7 clinical trial Sunday at…
September 02, 2009
September 2, 2009 – Abbott announced Monday at the European Society of Cardiology Congress the widespread availability…
September 02, 2009
September 2, 2009 – Volcano Corp. said this week it entered into a nonexclusive, global resale agreement with Siemens…
September 02, 2009
September 2, 2009 – A new analysis from the JUPITER study showed CRESTOR (rosuvastatin calcium) 20 mg reduced the…
September 01, 2009
September 1, 2009 - Evaluation of results of a multicenter study indicates that quantitative evaluation of the…
September 01, 2009
September 1, 2009 – Cordis Corp. said first patient has been enrolled in the CYPRESS study, which will assess…
September 01, 2009
September 1, 2009 – St. Jude Medical Inc. today announced European launch of the next generation version 4.0 of its…
September 01, 2009
September 1, 2009 – Sanofi-aventis said Sunday the investigational anti-Xa intravenous anti-coagulant otamixaban…
September 01, 2009
September 1, 2009 - BioClinica Inc., a clinical trial services provider, today announced that it has acquired the…
September 01, 2009
September 1, 2009 – AstraZeneca last week announced results from the phase III head to head trial, PLATO (A Study of…
